Stryker Corporation EPS Ratio 2011-2026 | SYK

EPS is a measure used to assess the financial stability and profitability of a company. EPS (Earnings Per Share) represents the company's net income divided by the number of its outstanding shares. This measure allows investors and analysts to evaluate the return on investment in the company's stock and compare it to other companies in the industry.

The term earnings per share (EPS) represents the portion of a company's earnings, net of taxes and preferred stock dividends, that is allocated to each share of common stock. The figure can be calculated simply by dividing net income earned in a given reporting period (usually quarterly or annually) by the total number of shares outstanding during the same term. Because the number of shares outstanding can fluctuate, a weighted average is typically used.
Calculated as:
EPS = (Net Income - Dividends on Preffered Stock) / Average Outstanding shares^[1]

EPS can be calculated as a simple ratio of net income to shares, or in various variations, such as diluted EPS, which takes into account the potential issuance of new shares or convertible securities.

A high EPS ratio usually indicates that the company has good profitability and efficiency in utilizing its assets. However, other factors such as sales growth, debt burden, and the company's competitive position should also be considered.

EPS ratio is an important indicator for investors when making decisions to buy or sell a company's stock. It is also used by analysts to assess the financial condition of the company and its potential for growth and development.

Annual EPS Ratio Stryker Corporation

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
2.21	1.43	8.34	6.23	5.29	4.26	5.57	9.5	2.73	4.4	3.82	1.36	2.66	3.41	3.48

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
9.5	1.36	4.31

Quarterly EPS Ratio Stryker Corporation

2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
2.25	2.32	1.71	2.18	2.17	2.07	1.82	1.95	1.56	-	2.16	1.73	0.86	1.75	1.17	1.57	0.8	1.51	1.66	-0.22	1.32	1.94	1.24	1.29	1.1	5.52	1.58	1.21	1.18	-0.66	1.16	1.04	1.19	1.36	0.95	1.02	1.08	1.39	0.8	1.04	0.59	0.68	0.16	0.34	0.19	1.02	0.27	0.56	0.8	0.71	0.93	0.85	0.92	1.05	0.85	0.8	0.79

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
5.52	-0.66	1.24

References

Khan, T. R., Islam, M. R., Choudhury, T. T., & Adnan, A. M. (2014). How earning per share (EPS) affects on share price and firm value.

EPS Ratio of other stocks in the Medical devices industry

Issuer	EPS Ratio	Price	% 24h	Market Cap	Country
Aethlon Medical AEMD	-8.58	$ 2.18	1.87 %	$ 3.4 M	USA
AdaptHealth Corp. AHCO	-0.52	$ 10.73	2.98 %	$ 1.45 B	USA
Allied Healthcare Products AHPI	-0.48	-	3.58 %	$ 2.21 M	USA
Butterfly Network BFLY	-0.34	$ 4.14	5.88 %	$ 876 M	USA
Acutus Medical AFIB	-2.81	-	-26.83 %	$ 2.62 M	USA
Cognyte Software Ltd. CGNT	-0.17	$ 8.52	1.67 %	$ 612 M	Israel
CONMED Corporation CNMD	1.52	$ 36.66	-2.0 %	$ 1.14 B	USA
Alphatec Holdings ATEC	-0.96	$ 12.71	0.87 %	$ 1.91 B	USA
Cytosorbents Corporation CTSO	-0.38	$ 0.69	6.15 %	$ 37.6 M	USA
Aziyo Biologics AZYO	1.29	-	1.37 %	$ 20.5 M	USA
Avinger AVGR	-23.3	-	-20.74 %	$ 369 K	USA
BIOLASE BIOL	-29.4	-	-13.19 %	$ 166 K	USA
EDAP TMS S.A. EDAP	-0.51	$ 4.16	4.95 %	$ 155 M	France
Boston Scientific Corporation BSX	1.96	$ 71.56	2.54 %	$ 106 B	USA
Establishment Labs Holdings ESTA	-1.72	$ 65.03	2.43 %	$ 1.93 B	Costa-rica
Conformis CFMS	-6.99	-	-	$ 16.4 M	USA
Apollo Endosurgery APEN	-0.98	-	-	$ 475 M	USA
Cutera CUTR	-2.87	-	-10.19 %	$ 1.99 M	USA
Dynatronics Corporation DYNT	-1.43	-	14.99 %	$ 929 K	USA
InMode Ltd. INMD	1.45	$ 13.64	1.56 %	$ 882 M	Israel
ClearPoint Neuro CLPT	-0.7	$ 11.14	1.0 %	$ 301 M	USA
IRIDEX Corporation IRIX	-0.59	$ 1.34	0.77 %	$ 21.6 M	USA
Axonics Modulation Technologies AXNX	-1.28	-	-	$ 3.31 B	USA
FONAR Corporation FONR	1.78	$ 18.42	-	$ 121 M	USA
Helius Medical Technologies HSDT	-14.6	$ 2.19	-0.23 %	$ 1.33 M	USA
LivaNova PLC LIVN	-4.45	$ 61.86	0.7 %	$ 3.37 B	Britain
GBS GBS	-2	-	-0.57 %	$ 7.12 M	USA
MiMedx Group MDXG	0.33	$ 4.5	1.93 %	$ 665 M	USA
Abbott Laboratories ABT	3.73	$ 111.24	1.17 %	$ 194 B	USA
Delcath Systems DCTH	0.08	$ 9.82	0.05 %	$ 352 M	USA
Bio-Rad Laboratories BIO	-25.6	$ 265.0	1.44 %	$ 7.48 B	USA
Nano-X Imaging Ltd. NNOX	-0.91	$ 2.56	-1.16 %	$ 150 M	Israel
Integra LifeSciences Holdings Corporation IART	-0.09	$ 9.27	2.89 %	$ 714 M	USA
AxoGen AXGN	-0.34	$ 32.87	0.08 %	$ 1.51 B	USA
Align Technology ALGN	5.63	$ 175.45	3.54 %	$ 13.1 B	USA
Bruker Corporation BRKR	0.76	$ 33.48	2.18 %	$ 4.99 K	USA
BioSig Technologies BSGM	-0.75	-	37.08 %	$ 85.7 M	USA
Apyx Medical Corporation APYX	-0.27	$ 3.86	5.07 %	$ 159 M	USA
OrthoPediatrics Corp. KIDS	-1.69	$ 17.24	0.76 %	$ 404 M	USA